Researchers at the University of Gothenburg in Sweden are developing a new way to diagnose cancer by examining changes in the structure of glycans (sugar molecules) in the body. results published In Cell Reports Methods.
A new diagnostic method is based on the study of glycans. Glycans are a type of sugar molecule structure associated with proteins in the cells of the human body. Changes in the structure of glycans can indicate the presence of diseases and the course of the inflammatory process. Scientists have tried to link the type of structural changes to specific diseases.
To do this, they analyzed data from approximately 220 patients suffering from eleven types of cancer. Using artificial intelligence, scientists detected differences in the glycan infrastructure depending on the type of cancer. Similar tools based on the study of glycans as cancer biomarkers have been previously developed by scientists, but they have not shown high accuracy and are unreliable. New technology using artificial intelligence will improve these indicators.
It is stated that tissue samples taken from cancer patients were used in the research. However, scientists hope that in the future it will be possible to monitor changes in the glycan infrastructure using blood or saliva tests. Researchers estimate it will take about five years to achieve these results.
Previous scientists I learnedThat calorie restriction can extend life.